Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP. Cunningham D, et al. Among authors: ostrowski j. J Clin Oncol. 2009 Nov 20;27(33):5513-8. doi: 10.1200/JCO.2009.24.2446. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858379 Clinical Trial.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).
Reed NS, Poole CJ, Coleman R, Parkin D, Graham JD, Kaye SB, Ostrowski J, Duncan I, Paul J, Hay A; Scottish Gynaecological Cancer Trials Group (SGCTG). Reed NS, et al. Among authors: ostrowski j. Eur J Cancer. 2006 Jan;42(2):179-85. doi: 10.1016/j.ejca.2005.09.022. Epub 2005 Dec 6. Eur J Cancer. 2006. PMID: 16337372 Clinical Trial.
Advancing Pharmaceutical Care in Community Pharmacies in Poland: A Blueprint for Enhanced Patient Care Quality.
Merks P, Kowalczuk A, Howell A, Białoszewski A, Strocka J, Krajewska E, Pinkas J, Ostrowski J, Staniszewska A, Neumann-Podczaska A, Brzozowska M, Augustynowicz A, Borowska M, Drab A, Herda J, Kaźmierczak J, Religioni U. Merks P, et al. Among authors: ostrowski j. Healthcare (Basel). 2024 Oct 23;12(21):2109. doi: 10.3390/healthcare12212109. Healthcare (Basel). 2024. PMID: 39517322 Free PMC article. Review.
Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures.
Unrug-Bielawska K, Earnshaw D, Cybulska-Lubak M, Kaniuga E, Sandowska-Markiewicz Z, Statkiewicz M, Rumienczyk I, Dąbrowska M, Kocik-Krol J, Klimkiewicz K, Urbanowicz M, Naumczuk B, Kozerski L, Krzykawski M, Mikula M, Ostrowski J. Unrug-Bielawska K, et al. Among authors: ostrowski j. Anticancer Res. 2024 Oct;44(10):4219-4224. doi: 10.21873/anticanres.17252. Anticancer Res. 2024. PMID: 39349000
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists.
Wurtz NR, Shirude PS, Cheney DL, Lupisella JA, Chattopadhyay AK, Baligar V, Seshadri B, Anjanappa P, Viet A, Valente MN, Hsu MY, Abousleiman M, Sarodaya S, Tagore DM, Dudhgaonkar S, Putlur S, Dierks EA, Ostrowski J, Wexler RR, Garcia R, Kick EK. Wurtz NR, et al. Among authors: ostrowski j. ACS Med Chem Lett. 2024 Aug 12;15(9):1500-1505. doi: 10.1021/acsmedchemlett.4c00172. eCollection 2024 Sep 12. ACS Med Chem Lett. 2024. PMID: 39291022
490 results